Sanofi · 16 hours ago
Clinical Research Director, Immunology & Inflammation (Rheumatology)
Morristown, NJ
Full-time
Onsite
Lead/Staff, Director/Executive
$201K/yr - $335K/yr
2+ years expSanofi is an innovative global healthcare company dedicated to improving people’s lives through science. The Clinical Research Director will create and execute clinical development plans for immunology and inflammation therapies, particularly in rheumatology, while collaborating with cross-functional teams and advancing scientific knowledge in the field.
Health CareLife SciencePharmaceuticalTherapeutics
Responsibilities
Create clinical development strategy and plans for one or more assets
Lead and coordinate cross-functional teams to design, implement, and execute clinical development plans and studies
Align clinical development strategy with the global project team and internal partners, such as clinical operations, translational medicine, regulatory affairs, biostatistics, drug discovery, drug safety, marketing
Advance the clinical development plan through internal management review
Lead a clinical sub team to design clinical studies and to create study protocols
Execute the clinical development plan in close collaboration with clinical operations
Advance scientific and clinical knowledge for immunology in rheumatologic diseases
Incorporate new trial, scientific and digital methodologies
Pro-actively progress study execution
Oversee the execution of clinical studies in compliance with internal SOPs, GCP, ICH guidelines and other regulations
Review documents supporting clinical development such as Investigator’s brochure, regulatory documents for IND / CTA, clinical sections of integrated development plans, and submission dossiers for regulatory approval
Engage with health authorities (contribute to health authority submissions (such as new drug application) and timely response to regulatory reviews)
Serve as a medical expert and provide strategic input to early-stage programs
Collaborate with external experts, key opinion leaders, and investigators to advance clinical research
Represent Sanofi at scientific conferences and regulatory meetings
Qualification
Required
MD or MD/PhD in a relevant scientific discipline with at least 2 years relevant experience in clinical development within the pharmaceutical industry, academia, or government agencies such as the NIH, FDA, or other equivalent national or international public health and regulatory organization
Experience/enthusiasm in advancing assets from discovery into clinical development (experience in pharma or academia)
Have experience in novel approaches to translational medicine
Have and maintain deep scientific, technical and clinical knowledge in immunologic/rheumatologic diseases
Expertise in autoimmune and inflammatory diseases, particularly in rheumatology
Demonstrate problem solving skills
Understand and keep updated with the pre-clinical, clinical pharmacology and clinical data relevant to the molecule of interest and the respective therapeutic area
Strong leadership skills with the ability to influence and collaborate effectively in a matrix environment
Excellent communication and presentation skills, with the ability to articulate complex scientific concepts to diverse audiences
Proven track record of scientific publications and presentations at international conferences
Benefits
High-quality healthcare
Prevention and wellness programs
At least 14 weeks’ gender-neutral parental leave
Company
Sanofi
Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.
10001+ employees
H1B Sponsorship
Sanofi has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (101)
2024 (68)
2023 (59)
2022 (78)
2021 (38)
2020 (38)
Funding
Current Stage
Public CompanyTotal Funding
$6.97BKey Investors
Blackstone Life SciencesEvotec
2025-10-28Post Ipo Debt· $3B
2025-06-17Post Ipo Debt· $1.74B
2025-03-05Post Ipo Debt· $1.59B
Leadership Team
Paul Hudson
Chief Executive Officer
Francois-Xavier Roger
Chief Financial Officer
Recent News
MarketScreener
2025-12-31
2025-12-30
Company data provided by crunchbase